focus
Previous article:
Drug repurposing or repositioning? The language matters
Next article: FDA advisers vote against ALS treatment from BrainStorm
Next article: FDA advisers vote against ALS treatment from BrainStorm
hotspot
hotspot
-
Why doctors need education on FDA device approval process
2025-09-30 00:59 -
Parkinson’s finding may lead to tests and, someday, treatments
2025-09-30 00:46 -
Test for long Covid? Researchers find new clue in blood samples
2025-09-30 00:36 -
Humana cuts profit projections as Medicare Advantage costs soar
2025-09-30 00:18 -
Biotech venture capitalists face new demands from investors
2025-09-29 23:23 -
Shingles, which affected Dianne Feinstein, is on the rise
2025-09-29 23:00